Abstract: A peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues, comprising a B epitope of a poly-?2,8 sialic acid attached to NCAM which is recognized by an anti-poly-?2,8 sialic acid (PSA) antibody, the use thereof and the preparation of a medicament for modulating NCAM functions, to be administered for the prevention and/or the treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer is disclosed.
Type:
Grant
Filed:
July 18, 2008
Date of Patent:
November 1, 2011
Assignees:
Centre National de la Recherche Scientifique, Universite de la Mediterranee Aix-Marseilles 2, Schafer-N, Universitaetsklinikum Hamburg-Eppendorf